Identification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults
Authors:
- Divyanshu DubeyDDDivyanshu Dubey
- Grayson BeecherGBGrayson Beecher
- M. Bakri HammamiMHM. Bakri Hammami
- Andrew M. KnightAKAndrew M. Knight
- Teerin LiewluckTLTeerin Liewluck
- James TriplettJTJames Triplett
- Abhigyan DattaADAbhigyan Datta
- Surendra DasariSDSurendra Dasari
- Youwen ZhangYZYouwen Zhang
- Calvin R. JerdeCJCalvin R. Jerde
- Stephen J. MurphySMStephen J. Murphy
Open Access
- 13 June 2022
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 79 (8) , 808-816
Abstract
Immune-mediated rippling muscle disease (iRMD) is a rare myopathy characterized by abnormal muscle excitability. It is usually electrically silent, exhibiting wavelike muscle contractions (rippling) and percussion- or stretch-induced muscle mounding.1 In contrast to hereditary rippling muscle disease (hRMD), associated to date with pathogenic variants in caveolin-3 (CAV3) or, less frequently, cavin-1 (CAVIN1) genes, patients with iRMD lack a defined genetic defect.2,3 Responsiveness to immunotherapy supports an autoimmune pathogenesis. Muscle acetylcholine receptor antibody positivity with or without clinical myasthenia gravis (MG) has been reported in association with iRMD, further favoring its potential immune-mediated etiology.4-6Keywords
This publication has 29 references indexed in Scilit:
- Electrically Active Immune-mediated Rippling Muscle Disease Preceding Breast CancerThe Neurologist, 2012
- Appropriate Use and Reporting of Uncontrolled Case Series in the Medical LiteratureAmerican Journal of Ophthalmology, 2011
- Fatal Cardiac Arrhythmia and Long-QT Syndrome in a New Form of Congenital Generalized Lipodystrophy with Muscle Rippling (CGL4) Due to PTRF-CAVIN MutationsPLOS Genetics, 2010
- MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexesJournal of Cell Biology, 2009
- Aquaporin-4–binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2Journal of Experimental Medicine, 2008
- Identification of skeletal muscle autoantigens by expression library screening using sera from autoimmune rippling muscle disease (ARMD) patientsJournal of Cellular Biochemistry, 2006
- Rippling muscle disease may be caused by “silent” action potentials in the tubular system of skeletal muscle fibersMuscle & Nerve, 2005
- Consequences of a novel caveolin‐3 mutation in a large German familyAnnals of Neurology, 2003
- Identification of Autoantibodies Associated with Rippling Muscles and Myasthenia Gravis That Recognize Skeletal Muscle Proteins: Possible Relationship of Antigens and Stretch-Activated Ion ChannelsBiochemical and Biophysical Research Communications, 1999
- Monoclonal antibody specific for the T-tubule of skeletal muscle.Journal of Histochemistry & Cytochemistry, 1986